Holen Sie sich die Stockscreener-App
2.67
0.74%
-0.02
Vorhandelsmarkt:
2.85
0.18
+6.74%
Schlusskurs vom Vortag:
$2.69
Offen:
$2.89
24-Stunden-Volumen:
224.17K
Relative Volume:
1.40
Marktkapitalisierung:
$81.80M
Einnahmen:
$6.21M
Nettoeinkommen (Verlust:
$-19.92M
KGV:
-2.5429
EPS:
-1.05
Netto-Cashflow:
$-16.76M
1W Leistung:
+9.43%
1M Leistung:
+19.20%
6M Leistung:
+1.52%
1J Leistung:
-10.10%
1-Tages-Spanne:
$2.605
$2.9319
1-Wochen-Bereich:
$2.37
$2.9319
52-Wochen-Spanne:
$1.99
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Firmenname
InspireMD Inc.
Sektor
Branche
Telefon
972 3 6917691
Adresse
4 Menorat Hamaor Street, Tel Aviv
Vergleichen Sie NSPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.67 | 82.41M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
129.93 | 221.54B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.79 | 156.19B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
381.49 | 144.43B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
89.64 | 114.47B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.09 | 46.53B | 5.69B | 4.15B | 623.10M | 6.95 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2016-01-07 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Eingeleitet | Oppenheimer | Outperform |
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
InspireMD Reports Second Quarter 2025 Financial Results - Stock Titan
InspireMD Inc. Outperforms Peers on Volume MetricsTrade Ready Stock Watch for Short Term Published - metal.it
InspireMD, Inc. SEC 10-Q Report - TradingView
InspireMD's Q2 2025 Earnings and Strategic Momentum: A Path to Profitability Amid Uncertainty - AInvest
Does InspireMD Inc. stock perform well during market downturnsUnlock daily stock market insights for success - Jammu Links News
What makes InspireMD Inc. stock price move sharplyInvest confidently with daily market forecasts - Jammu Links News
What analysts say about InspireMD Inc. stockHigh-impact stock picks - Jammu Links News
What is the dividend policy of InspireMD Inc. stockUnlock powerful market analysis and alerts - Jammu Links News
How volatile is InspireMD Inc. stock compared to the marketSuperior profit margins - Jammu Links News
What is InspireMD Inc. company’s growth strategyOutstanding yields - Jammu Links News
Is it the right time to buy InspireMD Inc. stockMaximize returns with strategic trading plans - Jammu Links News
How strong is InspireMD Inc. company’s balance sheetFree Predictions - Jammu Links News
InspireMD's Turnaround: Sustainable Progress or Fleeting Optimism? - AInvest
Investors in InspireMD (NASDAQ:NSPR) from five years ago are still down 60%, even after 11% gain this past week - Yahoo Finance
Is a relief rally coming for InspireMD Inc. holdersFree Strong Buy With Technical Confidence - Newser
Why InspireMD Inc. stock attracts strong analyst attentionAlpha Generation Strategy with Low Volatility - Newser
Strategies to average down on InspireMD Inc.Real Chart Based Opportunity Identification - Newser
When is InspireMD Inc. stock expected to show significant growthAccess high-quality stock research instantly - Jammu Links News
What earnings revisions data tells us about InspireMD Inc.Technical Chart Summary for Momentum Stocks - Newser
What is the risk reward ratio of investing in InspireMD Inc. stockFree Market Dynamics Reports - Jammu Links News
How does InspireMD Inc. compare to its industry peersBuild a portfolio with strong long-term growth - Jammu Links News
Is InspireMD Inc. a growth stock or a value stockBreakout profit opportunities - Jammu Links News
What are InspireMD Inc. company’s key revenue driversSignificant capital appreciation - Jammu Links News
How many analysts rate InspireMD Inc. as a “Buy”Discover stocks with superior performance - Jammu Links News
InspireMD Inc Director Gary Roubin Makes Substantial Purchase of 41,322 Shares - AInvest
Is InspireMD Inc. stock bottoming outBull Market Summary and Recovery Outlook - Newser
Is InspireMD Inc. still worth holding after the dipFree Exit Ready Momentum Stock Watchlist - Newser
Published on: 2025-08-01 19:28:21 - Newser
Even after rising 14% this past week, InspireMD (NASDAQ:NSPR) shareholders are still down 59% over the past five years - simplywall.st
InspireMD raises $58M through combined financings; shares up - MSN
InspireMD Inc expected to post a loss of 26 cents a shareEarnings Preview - TradingView
NSPR: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com
What MACD signals say about InspireMD Inc.Free Community Shared Smart Money Signals - Newser
What machine learning models say about InspireMD Inc.Trend Reversal Probability Forecast Update - Newser
InspireMD outlines Q3 2025 FDA approval target for CGuard Prime - MSN
Using data tools to time your InspireMD Inc. exitFree AI-Powered Trade Planning with Indicators - Newser
What’s the recovery path for long term holders of InspireMD Inc.Oversold Opportunity Scanner with RSI Data - Newser
What data driven models say about InspireMD Inc.’s futureInstitutional Holding Behavior Pattern Analysis - Newser
InspireMD Names Raymond W. Cohen to Board of Directors Amidst PMA Approval of CGuard Prime Carotid Stent System - AInvest
InspireMD Skyrocketed 18.25%—Could This Be the Start of a Breakout? - AInvest
InspireMD's Strategic Leadership Evolution: How Raymond W. Cohen's Appointment Strengthens Governance and Signals Long-Term Value Creation - AInvest
InspireMD Raises $40.1M in Private Placement Offering - TipRanks
InspireMD raises $58 million to fund US launch of carotid stent - Investing.com Nigeria
InspireMD appoints medtech veteran Raymond Cohen to board - Investing.com Australia
InspireMD Announces Combined Financings of $58 Million - The Manila Times
InspireMD, Inc. Appoints Raymond W. Cohen to Board of Directors - Quiver Quantitative
InspireMD Raises $58 Million in Combined Financings, Bolsters Balance Sheet - AInvest
InspireMD raises $58 million in equity financing and warrant exercise. - AInvest
InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors - GlobeNewswire
InspireMD Strengthens Board with MedTech Star Who Led $3.7B Axonics Sale to Boston Scientific - Stock Titan
InspireMD Raises $58M from Major Investors to Launch FDA-Approved Stroke Prevention Stent - Stock Titan
Finanzdaten der InspireMD Inc.-Aktie (NSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.00%
3.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):